Substance | Condition | Seq | Src | PMID | Dtl | Title |
Fucoidan | Alzheimer's Disease | 5 | PM | 36876791 | 📋 | Fucoidans inhibited tau interaction and cellular uptake |
Fucoidan | Alzheimer's Disease | 2 | PM | 31585867 | 📋 | Fucoidan serves a neuroprotective effect in an Alzheimer's disease model |
Fucoidan | Alzheimer's Disease | 1 | PM | 29260173 | 📋 | Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species |
Fucoidan | Alzheimer's Disease | 3 | PM | 28300775 | 📋 | Protective Effects of Fucoidan on Aβ25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice |
Fucoidan | Alzheimer's Disease | 4 | PM | 26325676 | 📋 | Fucoidan - An α-amylase inhibitor from Sargassum wightii with relevance to NIDDM |
Fucoidan | Multiple Sclerosis | 1 | PM | 19655293 | 📋 | Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan |
Fucoidan | Neurodegenerative Disease | 3 | PM | 33861265 | 📋 | Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention |
Fucoidan | Neurodegenerative Disease | 1 | PM | 21570441 | 📋 | Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells |
Fucoidan | Neurodegenerative Disease | 2 | PM | 19843098 | 📋 | Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia |
Fucoidan | Parkinson's Disease | 8 | PM | 32630523 | 📋 | Protective Effect of Fucoidan against MPP +-Induced SH-SY5Y Cells Apoptosis by Affecting the PI3K/Akt Pathway |
Fucoidan | Parkinson's Disease | 5 | PM | 31480724 | 📋 | Fucoidan Suppresses Mitochondrial Dysfunction and Cell Death against 1-Methyl-4-Phenylpyridinum-Induced Neuronal Cytotoxicity via Regulation of PGC-1α Expression |
Fucoidan | Parkinson's Disease | 6 | PM | 30700973 | 📋 | The Effect of Fucoidan on Cellular Oxidative Stress and the CatD-Bax Signaling Axis in MN9D Cells Damaged by 1-Methyl-4-Phenypyridinium |
Fucoidan | Parkinson's Disease | 4 | PM | 30090649 | 📋 | Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson's Disease |
Fucoidan | Parkinson's Disease | 2 | PM | 26828289 | 📋 | Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic mice |
Fucoidan | Parkinson's Disease | 3 | PM | 25399812 | 📋 | Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1 |
Fucoidan | Parkinson's Disease | 7 | PM | 23006515 | 📋 | Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia |
Fucoidan | Parkinson's Disease | 1 | PM | 19545563 | 📋 | Fucoidan protects against dopaminergic neuron death in vivo and in vitro |